Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate®)

Seminars in Thrombosis and Hemostasis

Volumn 28, Issue 2, 2002, Pages 203-213

  Auerswald, Günter ^a   Eberspächer, Bruno ^a   Engl, Werner ^a   Güthner, Christiane ^a   Koksch, Marie ^a   Kreuz, Wolfhart ^a   Nimtz, Antje ^a   Pindur, Gerhard ^a   Scheel, Horst ^a   Schreiber, Jörg D ^a   Siekmann, Jürgen ^a   Turecek, Peter L ^a   Wolf, Hans Heinrich ^a  

^a Children's Hospital   (Germany)

Author keywords

Acute bleeds; Clinical efficacy; Immunate; Surgery; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; RISTOCETIN;

ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

DIMERIZATION; DRUG COMBINATIONS; DRUG MONITORING; FACTOR VIII; FEMALE; HEMORRHAGE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; PERIOPERATIVE CARE; STERILIZATION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0036236134     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-27822     Document Type: Article

References (13)

1. Clinical study of the biological efficiency of a high-purity FVIII:C-vWF complex concentrate in non-bleeding patients with von Willebrand disease
2. A 4.5 years old patient with von Willebrand disease type 2A, subtype IIE undergoing two-sided herniotomy according to Rehbein under continuous infusion of Immunate STIM plus
3. Therapie eines kindes mit von willebrand-jürgens-syndrom typ II mit hochgereinigtem fviii-konzentrat
4. Kombinierte behandlung mit immunate STIM plus und minirin bei einem patienten mit mittelschwerem von Willebrand-syndrom im rahmen eines ausgedehnten kardiochirurgischen eingriffs
5. Treatment of von Willebrand patients with Immunate
6. Continuous infusion of FVIII and FIX concentrates: In vitro analysis of clinically relevant parameters
7. A method for assaying von Willebrand factor (ristocetin cofactor)
8. Assay of ristocetin co-factor using fixed platelets and a platelet counting technique
9. The determination of von Willebrand factor activity by collagen binding assay
10. The complex multimeric composition of factor VIII/von Willebrand factor
11. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex
12. A two-phase linear regression model for biologic half-life data